Impact of risk factors on different interval cancer subtypes in a population-based breast cancer screening programme.


Por: Blanch J, Sala M, Ibáñez J, Domingo L, Fernandez B, Otegi A, Barata T, Zubizarreta R, Ferrer J, Castells X, Rué M, Salas D and INCA Study Group

Fecha de Publicación: 21/10/2014
Resumen:
Interval cancers are primary breast cancers diagnosed in women after a negative screening test and before the next screening invitation. Our aim was to evaluate risk factors for interval cancer and their subtypes and to compare the risk factors identified with those associated with incident screen-detected cancers.

Direcciones
Blanch J: Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; European Higher Education Area (EHEA) Doctoral Programme in Public Health in Department of Pediatrics, Obstetrics and Gynecology, Preventive Medicine and Public Health, Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain
Sala M: Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; European Higher Education Area (EHEA) Doctoral Programme in Public Health in Department of Pediatrics, Obstetrics and Gynecology, Preventive Medicine and Public Health, Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain; Research network on health services in chronic diseases (REDISSEC), Barcelona, Spain
Ibáñez J: DIRECCIÓN GENERAL DE SALUD PÚBLICA, Valencia, Spain; Centre for Public Health Research (CSISP), FISABIO, Valencia, Spain
Domingo L: Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Research network on health services in chronic diseases (REDISSEC), Barcelona, Spain
Fernandez B: Galician Breast Cancer Screening Programme, Directorate for innovation and management of public health, Santiago de Compostela, Spain
Otegi A: Osakidetza Breast Cancer Screening Programme, Basque Country Health Service, Bilbao, Spain
Barata T: General Directorate of Health Care Programmes, Canary Islands Health Service, Las Palmas de Gran Canaria, Spain
Zubizarreta R: Galician Breast Cancer Screening Programme, Directorate for innovation and management of public health, Santiago de Compostela, Spain
Ferrer J: Department of Radiology, Hospital de Santa Caterina, Salt, Girona, Spain
Castells X: Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; European Higher Education Area (EHEA) Doctoral Programme in Public Health in Department of Pediatrics, Obstetrics and Gynecology, Preventive Medicine and Public Health, Universitat Autònoma de Barcelona (UAB), Bellaterra, Barcelona, Spain; Research network on health services in chronic diseases (REDISSEC), Barcelona, Spain
Rué M: Research network on health services in chronic diseases (REDISSEC), Barcelona, Spain; Department of Basic Medical Sciences, Biomedical Research Institut of Lleida (IRBLLEIDA)-University of Lleida, Lleida, Spain
Salas D: DIRECCIÓN GENERAL DE SALUD PÚBLICA, Valencia, Spain; Centre for Public Health Research (CSISP), FISABIO, Valencia, Spain
ISSN: 19326203





PLoS One
Editorial
PUBLIC LIBRARY SCIENCE, 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 9 Número: 10
Páginas: -s
WOS: 000343731200028
ID de PubMed: 25333936

MÉTRICAS